Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1017703000"
EBITDA="-177218000"
PERatio="None"
PEGRatio="None"
BookValue="3.865"
DividendPerShare="0"
DividendYield="0"
EPS="-3.38"
RevenuePerShareTTM="0.626"
ProfitMargin="0"
OperatingMarginTTM="-5.33"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-0.793"
RevenueTTM="33609000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-3.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.66"
AnalystTargetPrice="37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.684"
num_52WeekHigh="34.99"
num_52WeekLow="13.77"
num_50DayMovingAverage="17.16"
num_200DayMovingAverage="22.33"
SharesOutstanding="56855000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="18.99"
high="23.39"
low="18.99"
price="22.75"
volume="3522057.00"
latest_trading_day="2023-08-01"
previous_close="17.84"
change="4.91"
change_percent="27.5224%"
aroon_positive_momentum_days="1"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="1"
Volume_recent_avg="716834"
Change_recent_avg="0.01"
Delta_recent_avg="0.96"
Variance_recent_avg="0.48"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="625"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
